Since NRF2 has an important role in the transcription activity of antioxidant enzymes, it was demonstrated that the NRF2 knockout in the DU-145 prostate cancer cell line can increase oxidative damage in cells, improving cisplatin effects (56). This evidence concerns the gene NFE2L2 and prostate carcinoma.